FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Endo USA, Inc.)

View source ↗

Summary

FDA approves Endo USA, Inc.'s generic mycophenolate mofetil original application (ANDA 203575), enabling its use to prevent organ transplant rejection in kidney…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

ORIG AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)